Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 47,521	$ 60,081
Short-term investments	250,869	215,765
Accounts receivable, net	19,306	14,867
Inventory	13,895	8,624
Prepaid expenses and other current assets	8,750	8,931
Total current assets	340,341	308,268
Property and equipment, net	801	1,341
Right-of-use asset	3,588	781
Intangible assets, net	6,388	7,028
Restricted cash	462	328
Other long-term assets	11,992	14,999
Total assets	363,572	332,745
Current liabilities:
Accounts payable	4,887	4,885
Accrued expenses and other current liabilities	54,797	48,262
Other current liability - LG Chem	36,635
Deferred revenue	1,286	1,286
Lease liability		770
Total current liabilities	97,605	55,203
Long-term liabilities:
Deferred royalty obligation	109,241	106,143
Lease liability, non-current	4,030	490
Derivative liability		1,150
Total liabilities	210,876	162,986
Commitments and contingencies (Note 15)
Series A convertible preferred stock, $0.001 par value: 150,000 shares authorized; 150,000 and 0 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively. Liquidation preference of $150,000 as of September 30, 2024.	141,481
Stockholders' equity:
Preferred stock, $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2024 and December 31, 2023
Common stock, $0.001 par value: 120,000,000 shares authorized; 61,436,251 and 59,426,559 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	61	59
Additional paid-in capital	1,123,768	1,064,302
Accumulated other comprehensive (loss) income	(604)	134
Accumulated deficit	(1,112,010)	(894,736)
Total stockholders' equity	11,215	169,759
Total liabilities, convertible preferred stock and stockholders' equity	$ 363,572	$ 332,745